Showing 41 - 60 results of 680 for search '"interferon"', query time: 0.07s Refine Results
  1. 41

    A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin by Nisha Mistry, Jonathan Shapero, Richard I Crawford

    Published 2009-01-01
    “…The present article reviews different presentations of drug-induced cutaneous eruptions, with a focus on eruptions reported secondary to the use of interferon and ribavirin. Presentations include injection site reactions, psoriasis, eczematous drug reactions, alopecia, sarcoidosis, lupus, fixed drug eruptions, pigmentary changes and lichenoid eruptions. …”
    Get full text
    Article
  2. 42

    Matrine relieved DHAV-1-induced hepatocyte excessive interferon and pyroptosis by activating mitophagy by Weiran Wang, Xiang Fu, Bolin Gu, Mengxin Hu, Jiaguo Liu

    Published 2025-01-01
    “…Additionally‌, by incorporating the autophagy inhibitor chloroquine, we observed that the effects of matrine on the regulation of excessive interferon (IFN) production, pyroptosis, mitochondrial damage, and oxidative stress were reversed. …”
    Get full text
    Article
  3. 43

    Association between Interferon-Inducible Protein 6 () Polymorphisms and Hepatitis B Virus Clearance by Geun-Hee Park, Kyoung-Yeon Kim, Sung Won Cho, Jae Youn Cheong, Gyeong Im Yu, Dong Hoon Shin, Kyu Bum Kwack

    Published 2013-03-01
    “…However, these cells are killed through HBV-induced apoptosis during the antigen-presenting period in HBV-induced chronic liver disease (CLD) patients. Interferon-inducible protein 6 (IFI6) delays type I interferon-induced apoptosis in cells. …”
    Get full text
    Article
  4. 44
  5. 45
  6. 46

    Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes by S.J.W. Kang, G.W. Eather, F. Qureshi, J.R. Scott

    Published 2024-10-01
    “…BACKGROUND: An ‘indeterminate’ interferon-gamma release assay (IGRA) result used in the diagnosis of latent TB infection (LTBI) is most commonly due to an inadequate control (or ‘mitogen’) response, which may reflect underlying T-cell dysfunction. …”
    Get full text
    Article
  7. 47

    Diagnostic Value of Interferon-Gamma Release Assays Combined with Multiple Indicators for Tuberculous Peritonitis by Xidong He, Yuanxue Gao, Qi Liu, Zhifang Zhao, Wanhang Deng, Hong Yang

    Published 2020-01-01
    “…To investigate the diagnostic value of interferon-gamma release assays combined with multiple indicators for tuberculous peritonitis. …”
    Get full text
    Article
  8. 48
  9. 49

    Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C by R. Rodríguez-Lojo, M. Almagro, J. M. Barja, F. Piñeyro, L. Pérez-Varela, J. Del Pozo, M. T. Yebra-Pimentel, E. Fonseca

    Published 2010-01-01
    “…Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. …”
    Get full text
    Article
  10. 50

    The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C by F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio

    Published 2012-01-01
    “…Very recently, three landmark genome-wide association studies identified single nucleotide polymorphisms near the interleukin 28B (IL28B) region which were more frequent in responders to treatment. IL28B encodes interferon (IFN)λ3, a type III IFN involved in host antiviral immunity. …”
    Get full text
    Article
  11. 51
  12. 52

    Ischemic Colitis During Pegylated Interferon-Alpha and Ribavirin Therapy for Chronic Hepatitis C by Yvette Leung, Stefan J Urbanski, Lynn Schindel, Robert P Myers

    Published 2006-01-01
    “…Rare cases of ischemic colitis associated with interferon-alpha (IFN-α) treatment for chronic hepatitis C (HCV) infection and metastatic cancer have been reported. …”
    Get full text
    Article
  13. 53
  14. 54
  15. 55
  16. 56

    Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis by Yaqin Chen, Gang Wu, Hongmin Zhang, Hua Xu, Hong Li, Ling Chen, Yixuan Yang, Peng Hu, Dazhi Zhang, Hong Ren, Huaidong Hu

    Published 2015-01-01
    “…This meta-analysis was performed to compare the effectiveness and risk of adverse events of interferon-based therapy with no treatment after liver transplantation. …”
    Get full text
    Article
  17. 57

    Tracheal Papilloma Treated with Cryotherapy and Interferon-α: A Case Report and Review of the Literature by Fatma Yıldırım, Murat Türk, Sedat Demircan, Nalan Akyürek, Ahmet Selim Yurdakul

    Published 2015-01-01
    “…Patient was treated with interferon-α (IFN-α) and he showed no recurrence at the 8th month of his therapy.…”
    Get full text
    Article
  18. 58
  19. 59

    Interferon‐β–Induced Injury During Pediatric Muscle Differentiation: Insight Into Juvenile Dermatomyositis Pathogenesis by Lauren T. Covert, Alaa Osman, George A. Truskey

    Published 2025-01-01
    “…Objective Juvenile dermatomyositis (JDM) involves up‐regulated type I interferons (IFNs), including IFNβ, yet pathologic mechanisms remain poorly understood. …”
    Get full text
    Article
  20. 60

    The Effects of Alpha Interferon on the Development of Autoimmune Thyroiditis in the NOD H2h4 Mouse by Yael Oppenheim, Grace Kim, Yoshiyuki Ban, Pamela Unger, Erlinda Concepcion, Takao Ando, Yaron Tomer

    Published 2003-01-01
    “…Alpha interferon (αIFN) therapy is known to induce thyroid autoimmunity in up to 40% of patients. …”
    Get full text
    Article